Skip to main content
Clinical Trials/JPRN-jRCTs031180361
JPRN-jRCTs031180361
Recruiting
Phase 2

A pilot study of prognostic significance of arterial 18F-NaF and 18F-FDG uptake in patients with aortic aneurysm

Jinzaki Masahiro0 sites150 target enrollmentMarch 18, 2019
Conditionsaortic aneurysm

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
aortic aneurysm
Sponsor
Jinzaki Masahiro
Enrollment
150
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 18, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Jinzaki Masahiro

Eligibility Criteria

Inclusion Criteria

  • 1\. over 20 years old
  • 2\. Patients with aortic aneurysm in which diameter is over 45 mm for thoracic aortic aneurysm or 40 mm for abdominal aortic aneurysm
  • 3\. Patients with aortic aneurysm which is judeged by ardiovascular surgens not to be necessary for surgery for at least 1 year at the time of informed consent.
  • 4\. Patient who agree to participate in this study.

Exclusion Criteria

  • 1\. Allergic to FDG and NaF solution
  • 2\. History of vasculitis, autoimmune disease, and collagen disease
  • 3\. History of Marfan syndrome
  • 4\. Hisotyr of chemotherapy and radiation therapy within 8 weeks
  • 5\. Definitly or potentially pregnant woman or lactating woman
  • 6\. Uncontrolable diabetes mellitus
  • 7\. Poor performance status
  • 8\. Difficulty in coming to hospital because of poor physical activity
  • 9\. History of pshychiatric disorders

Outcomes

Primary Outcomes

Not specified

Similar Trials